Buy SYNVISC® online at Kinami Health for professional orthopedic and medical aesthetic supply. SYNVISC® is a hylan G-F 20 viscosupplement used as an intra-articular knee osteoarthritis injection to support joint lubrication and help manage OA-related knee pain. Kinami Health supplies genuine SYNVISC® products, including single-injection Synvisc One and multi-injection options where available, with wholesale pricing, secure ordering and reliable delivery for clinics and licensed medical professionals.
Kinami Health makes it simple for clinics, orthopedic specialists and healthcare buyers to order SYNVISC® online with confidence.
When you buy SYNVISC® from Kinami Health, you benefit from:
SYNVISC® is designed for professional use only and should be administered by a qualified healthcare professional trained in intra-articular injection techniques.
SYNVISC® and SYNVISC-ONE® both contain hylan G-F 20, but they differ in treatment format.
SYNVISC® is commonly associated with a 3-injection treatment course. This option may be selected when a clinician prefers a staged approach to viscosupplementation.
SYNVISC-ONE® is the single injection viscosupplement option. It is supplied as a 6mL prefilled syringe and is designed for one intra-articular knee injection.
For buyers, the choice between SYNVISC® and SYNVISC-ONE® usually depends on the treatment protocol used by the clinic, patient suitability and stock requirements.
Available SYNVISC® products may include:
Before publishing, ensure that every product mentioned above is live in the product grid. If only Synvisc One is currently available, update this section to avoid listing unavailable SKUs.
SYNVISC® is part of Kinami Health’s wider orthopedic injections range and is often compared with Monovisc and Orthovisc.
SYNVISC® / SYNVISC-ONE® uses hylan G-F 20 and offers both multi-injection and single-injection treatment formats, depending on the product selected.
Monovisc is another single-injection viscosupplement option used for knee osteoarthritis treatment protocols. Buyers comparing Synvisc vs Monovisc often look at injection schedule, product composition, clinic preference and availability.
Orthovisc is typically positioned as a multi-injection hyaluronic acid viscosupplement option. Clinics comparing Orthovisc vs Synvisc vs Monovisc may evaluate the number of injections, formulation, ordering volume and patient treatment plans.
Explore related orthopedic brands:
SYNVISC® is a viscosupplement used to supplement the fluid inside the knee joint. In osteoarthritis, the natural synovial fluid may lose some of its lubricating and cushioning properties. SYNVISC® helps support joint lubrication through hylan G-F 20, a hyaluronan-based formulation designed for intra-articular use.
SYNVISC-ONE® is commonly chosen when a single-injection protocol is preferred. Depending on the patient and treatment plan, SYNVISC® products may provide knee osteoarthritis pain relief for up to six months.
For best results, patient assessment, product selection and injection technique should always be handled by a qualified healthcare professional.
SYNVISC® products are administered by intra-articular injection into the knee joint. The injection should only be performed by a trained healthcare professional using appropriate aseptic technique.
General administration considerations include:
SYNVISC-ONE® is administered as a single 6mL injection. Traditional SYNVISC® protocols may involve a course of three injections, depending on the product used and the clinician’s treatment plan.
As with other intra-articular knee injections, SYNVISC® may cause local reactions around the treated joint. These can include temporary pain, swelling, warmth, stiffness or fluid build-up in the injected knee.
SYNVISC® and SYNVISC-ONE® should not be used in patients with known hypersensitivity to hyaluronan products or in cases where infection is present in or around the target knee.
Patients should be assessed by a qualified healthcare professional before treatment, and any adverse reactions should be managed according to standard medical practice.
